These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7718674)

  • 1. Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism.
    George DT; Nutt DJ; Rawlings RR; Phillips MJ; Eckardt MJ; Potter WZ; Linnoila M
    Biol Psychiatry; 1995 Jan; 37(2):112-9. PubMed ID: 7718674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA; Koszycki D; Bradwejn J
    Depress Anxiety; 2004; 20(2):51-8. PubMed ID: 15390214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
    Koszycki D; Zacharko RM; Le Mellédo JM; Bradwejn J
    Depress Anxiety; 1998; 8(1):1-7. PubMed ID: 9750972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW
    Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
    Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J
    Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
    Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
    Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
    Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
    Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients.
    Golden RN; Hsiao JK; Lane E; Ekstrom D; Rogers S; Hicks R; Potter WZ
    Psychiatry Res; 1990 Jan; 31(1):39-47. PubMed ID: 2156276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-mediated phosphorylation of extracellular regulated kinases in platelets of patients with panic disorder versus controls.
    Martini C; Trincavelli ML; Tuscano D; Carmassi C; Ciapparelli A; Lucacchini A; Cassano GB; Dell'Osso L
    Neurochem Int; 2004 Jun; 44(8):627-39. PubMed ID: 15016478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls.
    Van Veen JF; Van der Wee NJ; Fiselier J; Van Vliet IM; Westenberg HG
    Eur Neuropsychopharmacol; 2007 Oct; 17(10):637-42. PubMed ID: 17481859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine responses to serotonergic agents in alcoholics.
    Lee MA; Meltzer HY
    Biol Psychiatry; 1991 Nov; 30(10):1017-30. PubMed ID: 1756196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From inducers of panic attack to neurobiology of panic disorder].
    Bourin M
    Encephale; 1996 Dec; 22 Spec No 5():35-41. PubMed ID: 9138945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL; Khan S; Liberzon I; Young EA
    Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-5-hydroxytryptophan induced increase in salivary cortisol in panic disorder patients and healthy volunteers.
    Schruers K; van Diest R; Nicolson N; Griez E
    Psychopharmacology (Berl); 2002 Jun; 161(4):365-9. PubMed ID: 12073163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alcohol and the serotonin system].
    Daoust M; Ernouf D; Narcisse G
    Ann Med Psychol (Paris); 1992; 150(2-3):143-6. PubMed ID: 1343508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine.
    Judd FK; Apostolopoulos M; Burrows GD; Norman TR
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):329-37. PubMed ID: 8208982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
    Terao T; Yoshimura R; Ohmori O; Takano T; Takahashi N; Iwata N; Suzuki T; Abe K
    Biol Psychiatry; 1997 May; 41(9):974-8. PubMed ID: 9110103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin in panic disorder and social phobia.
    Sheehan DV; Raj BA; Trehan RR; Knapp EL
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():63-77. PubMed ID: 7911142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased 5-HT-mediated prolactin release in major depression.
    Anderson IM; Ware CJ; da Roza Davis JM; Cowen PJ
    Br J Psychiatry; 1992 Mar; 160():372-8. PubMed ID: 1562864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin regulation of the human stress response.
    Hood SD; Hince DA; Robinson H; Cirillo M; Christmas D; Kaye JM
    Psychoneuroendocrinology; 2006 Oct; 31(9):1087-97. PubMed ID: 16962720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.